Arguably an even important consideration for the era of biologics - perhaps frequency rather than dose…

Yup, if the guidance can’t be implemented it leads to variation too. Actually my biggest challenge is the long term advanced disease still getting quarterly MUGA for example

Time for a pragmatic and (real world) evidence based UK guideline me thinks. Scottish Breast SACT Group due to discuss local approach early 2025.